2024 is set to be a watershed year for #Psychedelics. Alongside an influx in biotech investment in the #UK, the wider industry has seen a number of significant milestones that are set to accelerate the sector, return confidence and advance innovations in #MentalHealth. Featuring Beckley Psytech, Filament Health, Lykos Therapeutics (formerly MAPS PBC), MindBio Therapeutics, Cybin Inc, MindMed and Negev Capital. Post re-share credit: By Stephanie Price at Psychedelic Health

Posted by CanMar at 2024-03-14 00:03:13 UTC